Home » Trump’s FDA Cuts Are Putting Drug Development at Risk

Trump’s FDA Cuts Are Putting Drug Development at Risk

Trump’s FDA Cuts Are Putting Drug Development at Risk

New SEC filings from pharmaceutical companies reveal Donald Trump and Elon Musk’s cost-cutting measures could slow drug research and delay FDA approvals. WIRED Read More 

 New SEC filings from pharmaceutical companies reveal Donald Trump and Elon Musk’s cost-cutting measures could slow drug research and delay FDA approvals.